NEURO2022
Advanced Search

Session Details

Symposia

[1S03m]Drug discovery based on novel therapeutic target to neuropsychiatric disorders in interdisciplinary research

Thu. Jun 30, 2022 9:00 AM - 11:00 AM JST
Thu. Jun 30, 2022 12:00 AM - 2:00 AM UTC
Room 3 Conference Building B1 (Okinawa Convention Center)
Chair: Daisuke Ibi, AKIHIRO MOURI

[1S03m-Introduction]Introduction

[1S03m-01]Identification of molecules involved in the pathophysiology of schizophrenia using omics technology and development of biomarkers

*Akira Yoshimi1 (1. Fac Pharm, Meijo Univ, Nagoya, Japan)

[1S03m-02]PERK dysfunction as a molecular and cellular pathophysiology in the brain of patients with 22q11.2 deletion syndrome and its significance

*Yuko Arioka1,2 (1. Nagoya Univ Hosp, Aichi, Japan, 2. Dept Psych, Grad Sch Med, Nagoya Univ, Aichi, Japan )

[1S03m-03]Validity of serotonin 5-HT2A receptor in the lateral septum as a therapeutic target of stress-related disorders

*Daisuke Ibi1 (1. Dept Chem Pharmacol, Meijo Univ, Nagoya, Japan)

[1S03m-04]Development of biomarker and therapeutic agents for psychiatric disorders focusing on alteration of tryptophan metabolism

*Akihiro Mouri1,4, Kazuo Kunisawa1, Kuniaki Saito2,4, Toshitaka Nabeshima3,4 (1. Department of Regulatory Science for Evaluation and Development of Pharmaceuticals and Devices, Fujita Health University Graduate School of Health Sciences, 2. Department of Diseases Control and Prevention, Fujita Health University Graduate School of Health Sciences, 3. Advanced Diagnostic System Research Laboratory, Fujita Health University Graduate School of Health Sciences, 4. Japanese Drug Organization of Appropriate Use and Research)

[1S03m-05]Structural biology of GPCRs for drug discovery

*Ryoji Suno1 (1. Kansai Medical University)

[1S03m-06]Drug Discovery Research in Academia Targeting Orexin Receptors

*Noriki Kutsumura1 (1. University of Tsukuba)

[1S03m-Closing]Closing Remarks

Back to Category List